BioShield Technologies Announces EPA Approval of Two Registrations.

ATLANTA--(BUSINESS WIRE)--Oct. 19, 1998--BioShield Technologies, Inc. (Nasdaq SmallCap:BSTIU) today announced that the Environmental Protection Administration (the "EPA") has conditionally registered two of its core-active products.

AM500 and 500I provide residual inhibition of microorganisms responsible for odor, deterioration, and discoloration. The long list of EPA approved uses and articles includes such common articles as socks, shower curtains, and toilet seat covers. BioShield AM500 is an end-use product containing 5% of the active ingredient in water. The active ingredient is capable of bonding to surfaces and is further diluted with water before application. BioShield AM500I is for manufacturing use only and contains 5% of the same active ingredient. This product can be used by manufacturers to reduce deterioration of their products by microorganisms.

According to President Timothy C. Moses, "These EPA approvals will create greater opportunities for the Company to better expand its opportunity and inform the public regarding the unique properties of our microbiostatic residual active technology."

BioShield already has several products on the market in the Industrial and Institutional and consumer segments. The Company's consumer products, BioShield Protectant and BioShield Carpet & Upholstery Cleaner are available in supermarket chains including Kroger, A&P, Winn Dixie, and Cub Foods/Super Valu in Ga. and Winn Dixie in north Fla., and under the Duralast brand through independent distributors in the Industrial and Institutional market. These consumer products provide long-term protection against mold, mildew, stains, and odors.

BioShield Technologies, Inc. develops and markets microbiostatic products with a variety of retail, industrial, and institutional applications.

Statements in this press release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including, but not limited to, risks and uncertainties related to new developing technologies, dependence on collaborative partners, the inherent complexity and uncertainty regarding the development of products, BioShield's early-stage development, the result of research and development efforts, future capital needs, and the uncertainty of additional funding and government regulations and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof.